Hepanova
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
401 Professional Dr Ste 108, Gaithersbur...Phone Number
(240) 702-0066Website
www.hepanova.comRevenue
<$5 MillionIndustry
About Hepanova
Hepanova Org Chart
Is Hepanova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Hepanova, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Hepanova has new funding data
Earning: See what the market has to say on Hepanova recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Hepanova
Product Launch: Get notified when Hepanova launches new products
Click to see if Hepanova had a recent Job posting/layoffs
Check out if Hepanova is spiking on competitors!
Check if Hepanova has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Hepanova is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hepanova is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hepanova.
Hepanova financials insights
Gather financial insights about Hepanova, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$83K
Hepanova Tech Stack
A closer look at the technologies used by Hepanova
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hepanova
Hepanova Inc is a clinical-stage biotechnology company focused on developing first-in-class therapeutics for chronic liver disease and inflammation. Their lead clinical candidate, HPN-01, is an oral, long-acting IKKα/β inhibitor designed to address unmet needs in conditions such as MASH and inflammatory bowel disease. The company aims to provide in... Read More